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INTRODUCTION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION 
 
 
 
 Injury to glomeruli results in a variety of signs and symptoms of 
disease, including proteinuria, hematuria, azotemia, oliguria, edema and 
hypertension. Specific glomerular diseases tend to produce particular syndromes 
of renal dysfunction; although multiple glomerular diseases can produce the same 
syndrome. Evaluation of pathogenic features identified in a renal biopsy specimen 
may be required for definitive diagnosis. In patients with glomerular disease, renal 
biopsy provides tissue that can be used to determine the cause, predict the 
prognosis, and direct the treatment. In the absence of comprehensive knowledge of 
disease etiology, most glomerulopathies are still classified and named according to 
their morphologic features. The major inflammatory glomerulopathies are focal 
proliferative glomerulonephritis (termed mesangial proliferative 
glomerulonephritis if the proliferating cells are predominantly mesangial cells), 
diffuse proliferative glomerulonephritis, and cresentic glomerulonephritis. These 
diseases typically present with a nephritic- type active urine sediment 
characterized by the presence of red blood cells, red blood cast, leukocytes, and 
subnephrotic proteinuria  .The severity of renal insufficiency varies in proportion 
to the degree of glomerular inflammation.  
 
 
 
AIM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
AIM 
 
To evaluate the renal histopathology of patients with glomerular disease (with  
 
Significant Proteinuria > 1 gms / 24 hours) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REVIEW OF 
LITERATURE  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  The glomerulus is a modified capillary network that derives an ultrafiltrate 
to Bowman’s space, the most proximal portion the renal tubule. Approximately 
1.6 million glomeruli are present in two mature kidneys and collectively they 
produce 120 to 180 L of ultrafiltrate daily. Glomerular filtration rate is dependent 
on glomerular blood flow, ultrafiltration pressure, and the area and composition of 
the filtration barrier. These parameters are tightly regulated through changes in 
afferent and efferent arteriolar tone and mesangial cell contractility. Arteriolar 
tone and mesangial cell contractility are in turn, modulated by neurohumoral 
factors, local myenteric reflexes, and endothelium-derived vasoactive substances. 
In health, the glomerular endothelium is also antithrombotic and antiadhesive for 
leukocytes and platelets, thereby preventing inappropriate vascular thrombosis and 
inflammation during the filtration process. Filtration of plasma proteins and all 
blood cells is normally prevented as a consequence of fenestrated glomerular 
endothelium, basement membrane, and foot processes and slit diaphragms of 
visceral epithelial cells. In keeping the physiological function of glomerulus, 
virtually all glomerular injury results in impairment of glomerular filtration and/or 
the inappropriate appearance of plasma proteins and red blood cells in the urine. 
 
 The major morphologic patterns affecting the glomerular filtration barrier 
of proteins, namely the glomerular basement membrane and visceral epithelial 
cells, are membranous glomerulopathy, minimal change disease and focal and 
segmental glomerulosclerosis (FSGS). These entities typically present with 
nephritic – range proteinuria and the presence of relatively few red blood cells, 
leukocytes, or cellular casts. As a consequence of the heavy proteinuria, nephrotic 
syndrome was associated with hypoalbuminemia, edema, hyperlipidemia and 
lipiduria and a prothrombotic state. Membranoproliferative glomerulonephritis, as 
the name suggests, is a hybrid lesion that presents with a combination of nephrotic 
and nephritic features.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 DETERMINANTS OF GLOMERULAR INJURY 
 
 The important determinants of the extent and severity of glomerular injury, 
and accordingly of the clinical presentation, include 
1. The nature of the primary insult and the secondary mediator systems that it 
provokes 
2. The site of injury within the glomerulus and  
3. The speed of onset, the extent, and the intensity of disease. 
 Glomeruli are susceptible to a variety of inflammatory, metabolic, 
hemodynamic, toxic, and infectious insults. Most glomerular disease is triggered 
by immune attack, metabolic stress, or mechanical stress. Diverse insults can 
induce similar clinicopathological presentations, suggesting marked overlap 
among dowmstream molecular and cellular responses. 
 The consequences of injury at different sites within tne glomerulus can 
predicted from the physiological functions of the cells within the local milieu. The 
major sequelae of injury to the endothelium and subendothelial aspect of the GBM 
are  
1. Recruitment of leukocytes leading to inflammatory glomerulonephritis, or 
2. Perturbed hemostasis leading to thrombotic microangiopathy.  
 It is usual for one of these parameters to dominate; however, hybrid lesions may 
occur. Internal vasoconstriction and mesangial cell contraction can complicate each 
phenotype and thereby contribute to renal failure; Injury localized to mesangial area 
typically presents as asymptomatic abnormalities of urinary sediment and mild renal 
insufficiency. Proteinuria dominates the clinical presentation of injury to the subepithelial 
aspect of GBM and visceral epithelial cells. As with mesangial injury, GFR is often 
mildly compranised in this setting unless there is concomitant tubulointerstitial injury. 
The classic pathological manifestation of parietal cell injury is crescent formation, which 
typically presents with acute or subacute renal failure. Crescents can be the dominant 
morphologic presentation of glomerular disease or complicate proliferative or 
membranous lesions. 
 
IgA nephropathy 
IgA nephropathy (Berger’s disease, IgAN) is an immunopathologic entity 
characterized by deposition of granular immunoglobulin A, and frequently C3 in 
the glomerular mesangium. 
 Nephritis is present in 80% of patients and manifests as a nephritic urine 
sediment and moderate proteinuria. Macroscopic hematuria and nephritic – range 
proteinuria are uncommon. 
 Light – microscpic appearance can vary from mild mesangial proliferation 
and expression of diffuse proliferation with glomerular crescents. 
 The sine qua non for diagnosis is the presence of mesangial IgA deposition 
on immunofluorescence microscopy. IgA and C3 are also detected. Electron 
microscopy reveals mesangial immune deposits. Immune complexes may also be 
present in the peripheral glomerular capillary wall and paramesangial areas. 
Minimal change disease 
 
  
 MCD accounts for 80% of nephritic syndrome in children younger than 16 
years than 20% in adults .The peak incidence is between 6 and 8 years. Patients 
typically present with nephritic syndrome and benign urinary sediment. 
Microscopic hematuria is present in 20 to 30 %. Hypertension and renal failure are 
very rare.  
 MCD (also called nil disease, lipid nephrosis, or foot process disease) is so 
named because glomerular size and architecture are normal by light microscopy. 
Immunofluorescence studies are typically negative for immunoglobulin and C3. 
The findings of mesangial hypercellularity and sparse deposits of C3 and IgM 
portend a worse prognosis. Electronmicroscopy reveals characteristic diffuse 
effacement of the foot processes of visceral epithelial cells.  
 The etiology of MCD is uncommon, and the vast majority of cases are 
idiopathic. MCD occasionally develops after upper respiratory tract infection, 
immunizations, and atopic attacks. 
 In children, the urine contains albumin principally and minimal amounts of 
higher molecular weight proteins such as alpha 2 macroglobulin and IgG. This 
selective proteinuria in conjugation with foot process effacement suggests injury 
to podocytes loss of fixed negative charge in the glomerular filtration barrier for 
protein. Proteinuria is typically nonselective in adults, suggesting more extensive 
perturbation of membrane permeability. 
 
Focal Segmental Glomerular Disease 
 
 
 The pathagnomonic morphologic lesion in FSGS is sclerosis with 
hyalinosis involving portions (segmental) of fewer than 50% (focal) of glomeruli 
on tissue section. The incidence of idiopathic (primary) FSGS had increased over 
the past two decades so that it now accounts for about one – third of cases of 
nephritic syndrome. Secondary FSGS can complicate a number of systemic 
diseases and sustained glomerular capillary hypertension following nephron loss 
from any cause.  
 Idiopathic FSGS typically presents as nephritic syndrome (66%) or 
subnephrotic proteinuria (33%) in association with hypertension, mild renal 
insufficiency, and abnormal urine sediment that contains red blood cells and 
leukocytes. Proteinuria is non selective in most cases. 
 Light microscopy of renal biopsy tissue reveals FSGS with entrapment of 
amorphous hyaline material, a process that shows a predilection for 
juxtamedullary glomeruli. Electron microscopy reveals evidence of damage to 
visceral epithelial cells.  
  
 The etiology of primary FSGS is unclear, but appears to be, at least in part, 
immunological.There is evidence that a circulating non immunoglobulin 
permeability factor, possibly a lymphokine, triggers FSGS in at least a subgroup of 
patients. Plasmapharesis has been employed with variable success to control the 
nephrotic syndrome in this group. Secondary FSGS is a potential long-term 
consequence of nephron loss from any cause. 
 
 
 
Membranous Nephropathy  
 
 This morphologic lesion is a leading cause of idiopathic nephritic syndrome 
in adults (30-40%) and a rare cause in children (<5%). It has a peak incidence 
between the ages of 30 to 50 years and a male – female ratio of 2:1. Membranous 
nephropathy derives its name from the characteristic light microscopic appearance 
on renal biopsy, namely diffuse thickening of the GBM, which is more apparent 
upon staining with periodic acid-schiff (PAS). Most patients (>80%) present with 
nephritic syndrome, proteinuria usually being nonselective. Microscopic 
hematuria is present in up to 50% of cases. Hypertension is documented in only 10 
to 30% of patients at the outset but is common later in patients with progressive 
renal failure. Serologic test such as anti nuclear antibody, ANCA, anti-GBM 
antibody,cryoglobulin titers and complement levels are normal in the idiopathic 
form 
 Light microscopy of the renal biopsy section reveals diffuse thickening of 
the GBM without evidence of inflammation or cellular proliferation. 
Immunofluorescence reveals granular deposition of IgG, C3 and the terminal 
components of compliment along the glomerular capillary wall. 
 The pathogenesis of idiopathic human membranous glomerulopathy is 
incompletely understood .The presence of electron – dense immune deposits that 
contain IgG and C3 suggest an immune process. About one third of adult 
membranous nephropathy occurs in association with systemic diseases such as 
SLE, infections such as hepatitis B, malignancy and drug therapy with gold and 
penicillamine.   
 
 
Membrano Proliferative Glomerulonephritis 
 This morphologic entity, also known as mesangiocapillary 
glomerulonephritis, is characterized by thickening of the GBM and proliferation 
changes on light microscopy. Two major types are identified; both are 
characterized by a diffuse increase in mesangial cellularity and matrix, and by 
thickening and reduplication of the GBM such that the lobular pattern of the 
glomerular tuft is exaggerated. The hallmark of type I MPGN is the presence of 
subendothelial and mesangial deposits on electron microscopy that contain C3 and 
IgG or IgM; rarely IgA deposits are demonstrated by immunofluorescence 
microscopy.The hallmark of type II MPGN (dense deposit disease) is the presence 
of electron-dense deposits within the GBM and other renal basement membranes 
that stain for C3, but little or no immunoglobulin. 
 Most patients with type I MPGN present with heavy proteinuria or 
nephritic syndrome, active urinary sediment, and normal or mildly impaired 
GFR.C3 levels are usually depressed and C1q and C4 levels are borderline or low. 
Type MPGN is an immune-complex glomerulonephritis and can be associated 
with a variety of chronic infections, systemic immune complex disease and 
malignancies 
 Type II MPGN can also present with proteinuria and nephritic syndrome; 
however, some patients present with nephritic syndrome, RPGN or recurrent 
macroscopic hematuria. Type II MPGN is an autoimmune disease in which 
patients have an IgG autoantibody, termed C3nephritic factor, that binds to C3 
convertase, the enzyme that metabolizes C3, and renders it resistant to inactivation 
.Type II MPGN runs a variable course; the GFR remains stable in some patients 
and declines gradually to ESRD over five to ten years in others.  
 
Mesangio Proliferative Glomerulonephritis 
 
 In 5 to 10% of patients with idiopathic nephrotic syndrome, renal biopsy 
reveals a diffuse increase in glomerular cellularity, predominantly due to 
proliferation of mesangial and endothelial cells, and infiltration by monocytes. 
Findings on immunofluorescence microscopy vary and include deposits of IgA, 
IgG, IgM, and /or complement, or absence of immune reactants. It is likely that 
this morphologic entity is, in fact, a heterogeneous group of diseases that includes 
atypical forms of MCD and FSGS and milder or resolving forms of the immune-
complex and pauci-immune glomerulopathies described above under nephritic 
syndrome and RPGN. In keeping with the heterogeneity of this diagnosis, the 
prognosis is variable. In general, persistent nephritic –range proteinuria signals a 
poor prognosis, with many patients progressing to ESRD over 10 to 20 years 
despite immunosuppressive therapy. 
 
Renal Amyloidosis 
 
 Amyloidosis is classified according to the major component of its fibrils. 
There is substantial overlap in renal clinicopathologic presentations of amyloid 
(AL) and amyloid A (AA). Glomeruli are involved in 75 to 90% of patients 
usually in association with involvement of other organs. The clinical correlate of 
glomerular amyloid deposition is nephrotic-range proteinuria. In addition, >50% 
of patients have impaired glomerular filtration at diagnosis. Hypertension is 
present in about 20 to 25%. Renal size is usually normal or slightly enlarged. A 
minority of patients present with renal failure due to amyloid deposition in renal 
vasculature with fanconi’s syndrome, nephrogenic diabetes insipidus, or renal 
tubular acidosis due to involvement of the tubulo interstitium. Rectal biopsy and 
abdominal fat pad biopsy reveal amyloid deposits in about 70% of patients and 
may obviate the need for renal biopsy. 
 Renal biopsy gives a very high yield if there is clinical evidence of renal 
involvement. The earliest pathologic changes are mesangial expansion by 
amorphous hyaline material and thickening of the GBM. Further amyloid 
deposition results in the development of large nodular   eosinophilic masses. When 
stained with congo red, theses deposits show apple-green birefringence under 
polarized light. Electron microscopy the characteristic non-branching extra 
cellular amyloid fibrils of 7.5 to 10 nm in diameter. Tubulointerstitial and vascular 
deposits of amyloid are also seen and may occasionally be more predominant than 
glomerular deposits. 
 
 
Lupus Nephritis 
 
 Nephritis is usually the most serious manifestation of SLE. Since nephritis 
is asymptomatic in most lupus patients, urinalysis should be ordered in any person 
suspected of having SLE. The classification of lupus nephritis is primarily 
histologic. Renal biopsy is useful in planning current near future therapies. 
Patients with dangerous proliferative forms of glomerular damage usually have 
microscopic hematuria and proteinuria (>500 mg per 24 h); approximately one-
half develop nephrotic syndrome, and must develop ESRD within 2 years of 
diagnosis. Therefore, aggressive immunosuppression is indicated (usually 
systemic immunosuppression plus a cytotoxic drug), unless damage is irreversible. 
Usually 20% of the patients with DPGN die or develop ESRD within 10 years of 
diagnosis. Such individuals require aggressive control of SLE and of 
complications of renal disease and therapy. A small proportion of SLE patients 
with proteinuria (usually nephrotic) have membranous glomerular changes without 
proliferation on renal biopsy. There out come is better than for those with DPGN, 
but proteinuria is less likely to improve. Lupus nephritis tends to be an ongoing 
disease, with flares requiring re-treatment over many years. For most people with 
lupus nephritis, accelerated atherosclerosis becomes important after several years 
of disease; attention must be given to control of blood pressure, hyperlipidemia, 
and hyperglycemia. 
 In renal biopsies, the pattern of injury is important in diagnosis and in 
selecting the best therapy. The World Health Organisation (WHO) has classified 
lupus nephritis as  
Grade I – no histological changes 
Grade II – proliferative changes confined to the mesangium 
Grade III – proliferative changes in tufts of 10 to 50 % of glomeruli; higher  
         proportions of glomeruli affected suggest worse prognosis 
Grade IV – diffuse proliferative glomerulonephritis (DPGN) affecting >50% of  
          glomeruli. 
Grade V - predominantly membranous changes with various degrees of   
         proliferation 
Grade VI – end stage, scarred glomeruli. 
 In addition, pathologist report the extend of inflammatory (potentially 
reversible) and chronic (irreversible scarring in glomeruli, renal tubules, and blood 
vessels) changes. 
 In general, treatment for lupus nephritis is not recommended in patients 
with class I or II disease or with extensive irreversible changes. In contrast, 
aggressive immunosuppression is recommended for patients with class III, IV or V 
inflammatory proliferative lesions because the majority of those individuals, if 
untreated, develop end-stage renal disease (ESRD) within 2 years. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mechanisms of glomerular injury 
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In the normal person, urinary protein excretion is less than 150 mg per day (with 
most subjects being under 100 mg per day) and consists mostly of filtered plasma 
proteins (60%) and tubular Tamm-Horsfall proteins (40%). The main plasma 
protein in the urine is albumin, constituting about 20% of the total normal daily 
Mesangial 
Cells 
protein excretion. In normal subjects the daily amount of albumin is less than 20 
mg (15µg/min). 
Proteinuria usually reflects an increase in glomerular permeability for normally 
non-filtered plasma macromolecules such as albumin. A 24-hour urine collection 
containing more than 150 mg of protein is abnormal. Significant proteinuria is 
suspected when a dipstick test of the urine is persistently positive for protein. In 
such a situation the daily protein excretion will usually exceed 300-500 mg per 
day. Since the dipstick method can detect urine protein concentration of as little as 
30 mg/dL, a very concentrated urine specimen might test positive for protein even 
though the quantitative amount of proteinuria is less than 150 mg/day. 
The dipstick method for detection of proteinuria relies on a color change of the 
indicator dye—a reaction primarily dependent on the amount of albumin in the 
urine. The sulfosalicylic acid (SSA) method of protein detection may be useful in 
certain situations, but is generally not readily available in most clinical situations. 
The SSA method detects proteinuria by acid precipitation and detects any type of 
proteins in the urine 
 
 
Four important qualifications to the foregoing definitions are needed: 1.) Both 
dipstick and SSA will record false positive results for protein in the presence of 
radiocontrast agents.2.) Since the dipstick method is most sensitive for detection 
of albumin, disease states in which the proteinuria is mainly composed of heavier 
plasma proteins such as immunoglobulins or their light-chains (multiple myeloma 
or plasma cell dyscrasias) may be associated with a negative or weakly positive 
dipstick reaction for protein. The SSA method will give a strongly positive 
reaction and subsequent analysis of the urine for immunoglobulins or light-chains 
will verify that the proteinuria is due to proteins other than albumin. 3.) Dipstick 
and SSA will both detect urinary lysozymes that are increased in production and 
excretion in some patients with acute monocytic leukemia. 4.) In early diabetic 
nephropathy, persistent excretion of increased amounts of albumin in the range of 
30-300 mg daily is called microalbuminuria. Standard dipstick methodology might 
fail to detect such small but clinically important amounts of albuminuria. Hence 
using a specific assay for urinary albumin is the more sensitive and recommended 
technique. 
Microalbuminuria is defined by the presence of >30 and <300 mg of albuminuria 
daily. Since 24-hour urine collections are difficult to obtain, the measurement of 
the albumin to creatinine concentration in an untimed random urine specimen is 
used. The albumin to creatinine concentration of >30 mg per gram of creatinine 
correlates very well with a 24-hour urine albumin measurement. Its detection in 
Type I diabetes mellitus is the earliest clinical evidence of diabetic nephropathy. 
Transient increases in urinary albumin excretion may be seen in short-term 
hyperglycemia, exercise, urinary tract infections, marked hypertension, heart 
failure, and acute febrile illnesses. There is also diurnal variation in urinary 
albumin excretion. Confirmation of microalbuminuria requires verification on 2 or 
3 collections over 3 to 6 months. Transient and clinically insignificant dipstick 
proteinuria might occur in a variety of clinical states including febrile illnesses, 
following vigorous exercise, in congestive heart failure, and exposure to cold. 
Transient proteinuria might be seen in 4% of men and 7% of women on a single 
examination. In screening studies of asymptomatic healthy individuals, dipstick 
proteinuria on 2 consecutive occasions has been reported in from 0.5-5%. In the 
same studies, the positive predictive value of proteinuria identifying serious 
urogenital disease was 0-11%. Orthostatic proteinuria occurs primarily in older 
adolescents and is characterized by increased protein excretion in the upright 
position and normal protein excretion in the supine position (ie, as found in a urine 
sample taken early in the morning after the subject has been lying down). 
Orthostatic proteinuria is a benign condition. Persistent proteinuria, especially in 
clinical illnesses, or when accompanied by other urinary abnormalities, such as 
hematuria, proteinuria, or bacteruria, deserves further investigation. In one study 
of adults, IgA nephritis, membranous nephropathy, and focal and segmental 
glomerulosclerosis were the most common histologic diagnoses in patients with 
asymptomatic proteinuria and/or hematuria.  
There are 3 basic types of proteinuria—glomerular, tubular, and overflow.  
The glomerular filtration barrier is composed of the endothelial cell, the basement 
membrane, and the epithelial cell foot processes. Proteinuria occurring in 
glomerular disease is due to increased filtration of albumin and other 
macromolecules across the glomerular basement membrane. This occurs because 
of an alteration in both the charge selectivity and size selectivity of the glomerular 
barrier.  
Glomerular proteinuria 
Normally the basement membrane and endothelial cells possess a negative charge. 
Plasma albumin, which also possesses a negative charge, is repelled by the normal 
negative charge on the basement membrane and the intact endothelial cells. 
Circulating IgG has a neutral or positive charge and is not restricted by a negative 
charge on the basement membrane. Rather, immunoglobulins are restricted by the 
size selective barrier of the membrane and the epithelial slit diaphragm located 
across the spaces between the epithelial foot processes 
In glomerular disease, the injury to the glomerular basement membrane 
causes proteinuria due to a loss in negative charge as well as from an increase in 
the number of larger non-selective pores. Glomerular diseases are also 
accompanied by disruption and loss of the epithelial foot process covering of the 
basement membrane. It appears that the increased protein leakage occurs 
especially at the sites of this epithelial alteration. 
Tubularproteinueia 
Low molecular weight molecules such as B2 microglobulin, amino acids, and 
immunoglobulin light chains have a molecular weight of about 25000 (albumin is 
69000). These smaller proteins are easily filtered across the basement membrane 
and then completely reabsorbed by the proximal tubular cells. A variety of 
diseases that produce tubular and interstitial injury impair the tubular reabsorption 
of these molecules. Some glomerular diseases are also accompanied by tubular 
injury and tubular proteinuria. Standard dipstick methods will not detect these 
proteins. Specific urinary measurements of B2 microglobulin are quite sensitive 
for any tubular injury, but they are not specific for any disease.  
Overflowproteinuria 
Increased excretion of low molecular weight proteins might be seen in states 
where there is significant increased production of these proteins, as in multiple 
myeloma. The proteinuria results from the fact that the amount of these proteins 
filtered exceeds the reabsorptive capacity of the proximal tubule. 
Most patients with proteinuria have no signs or symptoms from the proteinuria. In 
states of heavy (nephrotic range) proteinuria exceeding 3 g daily, the patient might 
report foamy urine and might demonstrate edema. The foamy urine is due to 
increased lipid in the urine, which alters the surface tension of the urine. Lipiduria 
is caused by the filtration of lipoproteins across the damaged glomerular barrier. 
On urine microscopy lipiduria might appear as free fat, or as fat droplets in tubular 
cells or casts where they are referred to as oval fat bodies or fatty casts 
respectively. Edema, which frequently accompanies nephrotic range proteinuria, is 
caused by reduction of plasma oncotic pressure due to reduced plasma albumin. 
Hypoalbuminemia is the result of increased glomerular losses and defective 
synthesis of albumin. At times the hypoalbuminemia and loss in plasma oncotic 
pressure produce true intravascular volume depletion resulting in hypotension and 
pre-renal acute renal failure. The loss of albumin stimulates the liver synthetic 
activity, which also contributes to increased lipoprotein production and 
hyperlipidemia. 
In addition, a careful microscopic exam of recently voided centrifuged 
urine should be performed. The presence of bacteria and leukocytes will suggest 
urinary infection. The presence of leukocytes and leukocyte casts in the absence of 
bacteruria suggests interstitial nephritis. The presence of dysmorphic erythrocytes 
and erythrocyte casts suggests a nephritic syndrome such as an acute or subacute 
glomerulonephritis, IgA nephropathy, or membranoproliferative 
glomerulonephritis. The presence of fatty casts or oval fat bodies suggests that the 
patient has a glomerular disease associated with nephrotic syndrome or nephrotic 
range proteinuria. In patients with a benign urine sediment, acute renal failure and 
slightly positive dipstick for proteinuria, one should perform a sulfosalicylic acid 
(SSA) test of the urine. A strongly positive SSA and weakly positive dipstick 
proteinuria should lead one to suspect light chains in the urine and a diagnosis of 
some type of plasma cell dyscrasia. 
Quantification of protein excretion may be performed on a complete 24-hour urine 
specimen or by determining the protein:creatinine ratio in a random urine 
specimen. The protein:creatinine ratio has been validated and shown to compare 
favorably with complete 24-hour collection. Thus, a protein:creatinine ratio of less 
than 1 and greater than 3 is consistent with 24-hour protein excretions of less than 
one gram and greater than 3.5 g respectively. This method is also easier and likely 
to be more accurate since it does not require a 24-hour collection of urine.  
Quantification of protein excretion allows one to begin to differentiate among the 
various renal disorders causing proteinuria. Diseases may be grouped into those 
with less than 1-2 grams/day, and greater than 3.5 grams daily. Patients with less 
than 1-2 grams of proteinuria usually have tubulointerstitial disease, 
nephrosclerosis, polycystic kidney disease, orthostatic proteinuria, or benign 
glomerular disease such as IgA nephritis. Proteinuria of greater than 3.5 g per day 
is due to glomerular diseases. 
 
 
 
 
 
 
 
RENAL BIOPSY 
 
 While the procurement of kidney tissue allows a detailed morphological 
analysis, this is not always indicative of the patient’s diagnosis. This holds true 
particularly in patients in whom the renal manifestations are secondary to systemic 
disease. The prime aims of performing a renal biopsy are  
1. A histological determination of the type and severity of renal disease 
2. Deciding whether specific treatment (steroids, immunosuppression, 
plasmapheresis), could be beneficial, and 
3. Estimating prognosis and potential for reversibility of the lesion 
HISTORICAL PERSPECTIVE: 
 In 1923 Gywn first performed an open renal renal biopsy in patients with 
nephrotic syndrome. The first percutaneous renal biopsy is attributed to Ball, used 
an aspiration device to help diagnose a hypernephroma. 
PERCUTANEOUS BIOPSY PROCEDURE: 
 Biopsies are usually done in the morning after an over night fast. An 
intravenous access is placed. The patient lies on his abdomen on a firm table. With 
the patient in the prone position the operator working from the right hand side of 
the bed, the left kidney is nearest to the operator. 
 Following localization with ultrasonogram, the skin site is marked and the 
surrounding area surgically cleansed, draped and infiltrated with a local anesthetic. 
After anesthetizing the deeper tissues, the biopsy needle is inserted through a 
small skin incision. The movements of the needle in relation to the patients 
breathing serve to guide the tip in relation to the kidney. On respiration when, the 
kidney moves independently under the tip of the needle, the needle is superficial to 
renal parenchyma. On penetrating the capsule, the needle will swing with a 
pendular motion, towards the head on inspiration and returning caudally on 
expiration. The needle may be seen to jerk free of the capsule, again assuming a 
motion independent of respiration. At this point the needle should be inserted 
downwards a few millimeters entering the renal cortex. Once inside the cortex, the 
needle will be fixed within the kidney and again on respiration will move in 
unison with it. On the cessation of breathing, the needle will also be seen to 
pulsate in accordance with the periodic flow of blood to the kidneys. 
 Once the needle is properly positioned in the renal cortex with the patient 
holding his breath, the specimen is cut and the needle withdrawn out. The 
inspection of the tissue pieces with a dissecting microscope for glomerular tufts 
ensues the adequacy of the biopsy specimen. The presence of at least six glomeruli 
for light microscopy is considered as a successful biopsy. 
COMPLICATIONS: 
 The most common complication encountered is hematuria. Microscopic 
hematuria occurs in virtually all patients, whereas gross hematuria is seen in 3- 
16% of biopsies. Perinephric hematomas are a common occurrence. Clinically 
significant hematomas are encountered in 0.2 to 2% of biopsies, manifesting as a 
flank mass and changes in vital signs in association with a fall in hematocrit. Other 
complications include: ileus, laceration of the liver, intestine, gall bladder, 
subcostal and visceral arteries, Pneumothorax; and puncture of the renal pelvis 
resulting in urinoma. Infections are uncommon except in case of pyelonephritis. 
CONTRAINDICATIONS: 
1. Solitary kidney / a sole functioning kidney. 
2. Uncontrolled hypertension.  
3. Hemorrhagic diathesis. 
4. Isolated large renal cyst. 
5. Uncooperative patient. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND 
METHODOLOGY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODOLOGY 
 
 
 
This is a prospective study of fifty consecutive patients attending the 
nephrology clinic in The Stanley medical college hospital, Chennai in whom 
ultrasonogram guided renal biopsy were done in patients with the following 
criteria 
 
INCLUSION CRITERIA: 
 
1. Patients aged  more than twelve years 
 
2. Proteinuria more than 1 gms / 24 hours 
 
 
EXCLUSION CRITERIA: 
 
1. All known cases of diabetes mellitus 
 
2. All known cases of systemic hypertension 
 
 
3. All known cases with contracted kidneys proved by ultrasonogram 
 
4. Post transplant patients 
 
5. Cases of nephrotic syndrome responding to immunosuppressive therapy 
 
 Renal biopsy helps in establishing accurate diagnosis, identifying any 
reversible pathology, helps in devising appropriate management plan for the 
patients and is very useful in understanding the histological nature of the disease 
The incidence of glomerular disease had increased dramatically in last decade and 
the pattern of glomerular pathology is changing dynamically with time .The type 
of glomerular disease varies in different geographies and among different age 
group of patients The amount of proteinuria, renal insufficiency, hypertension, and 
microscopic hematuria differ in different histopathological types and in different 
age groups .Hence all these parameters and the histopathological type of 
glomerular disease have prognostic implications in patients with glomerular 
disease Renal biopsy was performed in patients with glomerular disease 
(proteinuria <1 gms/24 hrs) attending the nephrology clinic from august 2004 to 
august 2006 All the biopsy specimen were evaluated by light microscopy and 
immunofluorescent staining. Laboratory investigations including twenty four hour 
urinary proteinuria, serum creatinine, hemoglobin, total leukocyte count, 
differential count, erythrocyte sedimentation rate, serum proteins, serum calcium, 
serum cholesterol, ultrasonogram of kidneys were done along with the 
histopathological analysis of kidney biopsy  
 
 
 
 
 
 
 
 
 
MINIMAL CHANGE DISEASE - PAS – STAINING 
 
 
 
 
 
 
 
FSGS – PAS STAIN - LOW POWER VIEW 
 
 
 
 
 
 
FSGS – PAS STAINING - HIGHPOWER VIEW 
 
 
 
 
 
 
 
IgA NEPHROPATHY – IMMUNOFLUORESCENCE STAINING 
 
 
 
 
 
FOCAL GLOMERULONEPHRITIS IN LUPUS ERTHEMATOSUS 
 
 
 
 
 
 
 
FSGS – HIGH POWER VIEW SHOWING HYALINE MASS  
AND LIPID SCLEROTIC AREA 
 
 
 
 
 
 
 
MEMBRANOUS GLOMERULONEPHRITIS PAS STAINING 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
RESULTS AND 
ANALYSIS 
 
 
 
 
AGE SEX DISTRIBUTION  
 
 
Age group ( in 
years) 
Male (%) Female (%)  Total (%) 
12- 20  7 (14%) 7 (14%) 14 (28%) 
21- 40 10 (20%) 20 (40%) 30 (60%) 
41-60 1 (2%) 5 (10%) 6 (12%) 
Total  18 (36%) 32 (64%) 50 (100%) 
 
The age sex distribution shows that  
The mean age of all the patients – 27.5 years 
Patients in age group 12- 20 – 18; 
  Males – 7, Females – 7. Mean age – 14.85 years. 
Patients in age group 21 -40 years – 30;  
 Males -10, Females – 20.Mean age – 30.6 years 
Patients in the age group 41- 60 – 6; 
 Males -1, Females – 5, Mean age – 44.5 
 
 
 
 
 
 
 
 
 
 
 
FREQUENCEY OF THE HISTOPATHOLOGICAL TYPES 
 
Histopathological type Number of cases (n) Number of cases (%) 
Focalsegmental 
glomerulosclerosis 
11 22 
IgA nephropathy 
 
8 16 
Minimal change disease 
 
8 16 
Mesangioproliferative 
glomerulonephritis 
7 14 
Membranous 
nephropathy 
6 12 
Lupus nephritis  
 
6 12 
Membranoproliferative 
glomerulonephritis  
3 6 
Amyloidosis  
 
1 2 
 
Among the 50 patients studied Focal segmental glomerulosclerosis (FSGS) was 
found in 11,IgA nephropathy and minimal change disease (MCD) in 8; 
Mesangiproliferative glomerulonephritis in 7, Membranous nephropathy and 
Lupus nephritis in 6, Membranoproliferative glomerulonephritis (MPGN) in 3 and 
Amyloidosis in 1 patient. 
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INCIDENCE OF RENAL INSUFFICIENCY 
 
HISTOPATHOLGICAL 
TYPE 
 
TOTAL PATIENTS 
PATIENTSWITH 
RENAL 
INSUFFICIENCY (%) 
Membranoproliferative 
glomerulonephritis 
3 3(100) 
Amyloidosis 
 
1 1(100) 
IgA nephropathy 
 
8 7(87.5) 
Lupus nephritis 
 
6 4(66.66) 
Mesangioproliferative 
glomerulonephritis 
7 4(57.14) 
Focalsegmental 
glomerulonephritis 
11 3(27.27) 
Membranous 
nephropathy 
6 1(16.66) 
Minimal change disease 
 
8 0(0) 
 
The incidence of renal insufficiency was common in patients with MPGN(100%) 
and amyloidosis (100%) , followed closely by FSGS (87.5%), lupus nephritis 
(66.66%),  mesangioproliferative glomerulonephritis (57.14%), FSGS (27.27%) 
and membranous nephropathy (16.66%). 
 
 
 
 
 
 
 
 
 
 
 
 
Incidence of Renal Failure
0
1
0 0 0
1 1
3
1
2
7
4
0
2
1
0
8
1
2
8
5
0
3
0
2
4
6
8
10
12
Amyloid FSGS IgA Lupus MCD Membranous MPGN Mesangio
Proliferative
Histopath types
N
o 
of
 p
at
ie
nt
s
Renal Failure - Male Renal Failure - Female No Renal failure
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SEVERITY OF RENAL INSUFFICIENCY IN VARIOUS  
 
HISTOPATHOLOGICAL TYPES  
 
 
 
HISTOPATH 
TYPE 
S.CREATININE
1.5 – 2.9 mg/dl 
S.CREATININE
3- 4.9 mg/dl 
S.CREATININE 
>5.0 mg / dl 
TOTAL
AMYLOIDOSIS 
 
 
0 
1 O 1 
FSGS 
 
2 
 
1 0 3 
IgAN 
 
3 
 
3 1 7 
LUPUS 
NEPHRITIS  
4 
 
0 0 4 
MCD 
 
0 
 
0 0 0 
MEMBRANOUS 
NEPHROPATHY 
1 
 
0 0 1 
MPGN 
 
0 
 
1 2 3 
MESANGIO 
PROLIFERATIVE  
4 
 
0 0 4 
TOTAL 
 
14 
 
6 3 23 
 
 
 
Of the 23 patients with renal insufficiency, number of patients with  
Serum Creatinine 1.5 to 2.9 mg/dl – 14 
Serum Creatinine 3.0 to 4.9 mg/dl – 6  
Serum Creatinine > 5 mg/dl - 3  
 
 
 
 
 
 
 
INCIDENCE OF HEMATURIA 
 
Patients with microscopic hematuria (>3 
RBC/HPF) 
Histopathological types 
Males  Females  Total  
IgAN 0 7 7 
FSGS 4 0 4 
Lupus nephritis 0 3 3 
MPGN 0 2 2 
Membranous GN 1 1 2 
MesangioproliferativeGN 2 0 2 
MCD 0 0 0 
Amyloidosis 0 0 0 
 
Total number of patients with microscopic hematuria – 20 
Number of males - 7  
Number of females – 13 
7 patients with IgAN, 4 with FSGS, 3 with lupus nephritis, and 2 with MPGN, 
membranous nephropathy, mesangioproliferative glomerulonephritis each had 
microscopic hematuria.   
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INCIDENCE OF HYPERTENSION 
 
Patients with Hypertension (BP>140/90 mm Hg) Histopath type 
Males  Females  Total  
IgAN 0 6 6 
Lupus nephritis 0 4 4 
MesangioproliferativeGN 3 1 4 
Membranous GN 1 2 3 
MCD 0 2 2 
FSGS 2 0 2 
MPGN 1 0 1 
Amyloidosis 0 0 0 
 
22 patients of the total 50 patients studied had Hypertension 
Males with Hypertension – 7 
Females with Hypertension – 15 
6 patients with IgAN, 4 with Lupus nephritis and mesangioproliferative 
glomerulonephritis each; 3 with membranous nephropathy, 2 with MCD and 
FSGS each; and 1 with MPGN had Hypertension.   
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AGE WISE DISTRIBUTION OF THE STAGES OF HYPERTENSION  
 
 
 
AGE GROUP  
In years 
STAGE 1 
BP (140-159/90-99) 
mmHg 
STAGE 2 
BP (>160/100) 
mmHg 
TOTAL 
12 – 20 1 1 2 
 
21-40 
 
11 6 17 
40-60 
 
1 2 3 
TOTAL 
 
13 9 22 
 
 
Hypertension is more common in the age group of 21 to 40 years – 11 patients  
 
STAGE I HYPERTENSION – BP 140-159/90-99 mmHg 
 
STAGE II HYPERTENSION – BP >160/100 mmHg 
 
Of the 22 patients with hypertension, number of patients with  
 
Stage I hypertension – 13(59.09%) 
 
Stage II hypertension – 9(40.09%) 
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PREVALANCE OF NEPHROTIC RANGE OF PROTEINURIA 
 
 
HISTOPATH 
TYPE 
SUBNEPHROTIC 
RANGE(<3.5gms/dl)
NEPHROTIC 
RANGE 
TOTAL 
AMYLOIDOSIS 
 
1 0 1 
FSGS 
 
5 6 11 
IgAN 
 
3 5 8 
LUPUS 
NEPHRITIS  
2 4 6 
MCD 
 
2 6 8 
MEMBRANOUS 
NEPHROPATHY 
1 5 6 
MPGN 
 
1 2 3 
MESANGIO 
PROLIFERATIVE  
3 4 7 
TOTAL 
 
18 32 50 
 
 
 
 
The amount of proteinuria was quantified and the patients were divided in toe 
groups as follows 
1. Nephrotic range (>3.5 gms/24 hours) – 32 (64%) patients  
2. Subnephrotic range (1 – 3.4 gms / dl) – 18 (36%) patients  
 
 
 
 
 
 
INCIDENCE OF ANEMIA 
 
 
Patients with Anemia (Hb <10 gms %)  Histopathological type 
Males  Females  Total  
FSGS 3 3 6 
MCD 2 3 5 
Lupus nephritis 0 4 4 
IgAN 0 4 4 
Membranous GN 1 2 3 
MesangioproliferativeGN 1 1 2 
MPGN 0 1 1 
Amyloidosis  0 1 1 
 
Patients with anemia – 26 
Males – 7 
Females – 19 
Anemia was found in 6 patients with FSGS, 5 with MCD, 4 with Lupus nephritis 
and IgAN each; 3 with membranous nephropathy, 2 with mesangioproliferative 
glomerulonephritis; and 1 each with MPGN and amyloidosis had anemia. 
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INCIDENCE OF HYPERLIPIDEMIA 
 
Patients with Hyperlipidemia (serum cholesterol 
>200 mg / dl) 
Histopathological type 
Males  Females  Total  
FSGS 6 5 11 
MCD 3 5 8 
IgAN 0 7 7 
Lupus nephritis 0 6 6 
MesangioproliferativeGN 4 1 5 
Membranous GN 3 2 5 
MPGN 1 2 3 
Amyloidosis  0 0 0 
 
Total number of patients with Hyperlipidemia – 45 
Males with Hyperlipidemia – 17 
Females with Hyperlipidemia – 28 
Hyperlipidemia is present in all the patients with FSGS, MCD, Lupus nephritis, 
MPGN, 7 with IgAN, 5 with mesangioproliferative glomerulonephritis and 
membranous nephropathy each. 
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INCIDENCE OF ELEVATED ESR 
 
Patients with elevated ESR (>25mm/Hour) Histopathological type 
Males Females  Total  
FSGS 4 5 9 
MCD 3 5 8 
IgAN 0 7 7 
MesangioproliferativeGN 4 2 6 
Lupus nephritis 0 6 6 
Membranous GN 1 3 4 
MPGN 1 2 3 
Amyloidosis 0 1 1 
 
Patients with elevated ESR – 44 
Males -13 
Females – 31 
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DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 
 All the fifty patients included in the study were in the age group of twelve 
to sixty years with a mean age of 27.54 years. All the fifty patients were divided in 
to three groups based on the age  
 
I – 12 to 20 years of age  
 
 There were 14 (28%) patients in this group with a mean age of 14.85 years  
 
II – 21 to 40 years of age  
 
 There were 30(60%) patients in this group with a mean age of 30.6 years  
 
III – 41 to 60 years of age  
 
 There were 6 (12%) patients in this group with a mean age of 44.5 years  
 
None of the patients were above 60 years of age  
 
 Of the 50 patients included in the study 32(64%) were females and 
18(36%) were males. The histopathological examination of the kidney biopsy 
revealed eight histopathological types.  Focal segmental glomerulosclerosis 
(FSGS) was the commonest type found in 11(22%) patients followed by  IgA 
nephropathy (IgAN) and minimal change disease (MCD) in 8(16%)patients each 
.Mesangioproliferative glomerulonephritis was found in 7(14%) patients , 
membranous nephropathy and lupus nephritis was found in 6(12%) patients 
each,3(6%) patients had membranoproliferative glomerulonephritis (MPGN) and 
1(2%) had amyloidosis.  
 
 
The comparison of the frequency of the various histopathological types in the 
present study with that of the studies conducted in various centers in India  
 
 
Histopath 
type  
 
Vellore 5 
(%) 
Jaipur 6 
(%) 
Chandigarh 7 
(%)           
Present Study
(%) 
Amyloidosis  
 
1.0 1.9 9.2 2.0 
FSGS  
 
16.8  5.3 29 22.0 
Membranous 
nephropathy 
9.5 17.4 4.0 12.0 
Mesangioprol
iferative GN 
7.3 6.7 10.1 14.0 
MPGN 
 
2.9 13.4 17.6 6.0 
IgAN 
 
8.4 7.8 2.0 16.0 
Lupus 
nephritis  
 
6.9 1.4 5.74 12.0 
MCD 
 
10.8 18.1 33.1 16.0 
 
 Except FSGS and mesangioproliferative glomerulonephritis which are 
common in males all other types are common in females in our study which is in 
contrast to the study conducted in Vellore where males dominated in all 
histopathological types barring lupus nephritis .MCD was the commonest 
histopathological type in the age group of less than twenty years of age, FSGS is 
the commonest type in 21 to 40 years of age group and mesangioproliferative 
glomerulonephritis above 40 years of age. Where as in the study in Vellore MCD 
was the commonest histopathological type in the age group of less than 15 years 
and FSGS, the commonest type in all other age groups  
 
 
 
FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) 
 
 Of the total fifty patients studied 11(22%) had FSGS on histopathological 
examination and this happened to be the commonest type found. Of the 11 patients 
with FSGS hypertension was found in only 2(18.18%) [Against 13.3% in the study 
by Jayakumar et al in madras medical college, chennai] 8, renal insufficiency in 
3(27.27%) [23.3% in the study by Jayakumar et al.] 8.4(36.36%) [Against 46.67% 
in the study by Jayakumar et al] 8. Of the patients with FSGS had microscopic 
hematuria .Of the 11` patients with FSGS nephrotic range proteinuria was present 
in 6(54.54%) and subnephrotic range of proteinuria in 5(45.45%) patients .of the 
11 patients with FSGS 2(18.18%) were in the age group of 12 to 20 years , 
8(72.72%) in the age group of 21 to 40 years and 1(9.09%) above 40 years of age 
.none of the patients with FSGS had hypocalcaemia (serum calcium < 8gms/ dl )  
or hyperlipidemia( serum cholesterol >200 mg /dl ) but  2(18.18%) patients had 
elevated ESR (>25 mm @ 1 hour )  
 
MINIMAL CHANGE DISEASE (MCD) 
 
 Minimal change disease was found in 8(16%) of the patients studied.Of the 
8 patients with MCD 5(62.50%) were in the age group of 12 to 20 years 
and3(37.50%) in the age group of 21 to 40 years and no MCD was found in 
patients above 40 years of age. None of the patients with MCD had renal 
insufficiency and none of them had microscopic hematuria .6(75%) of patients 
with MCD had proteinuria of nephritic range 2(25%) patients had stage 1 
hypertension and the remaining 6(75%) patients with MCD were normotensive 
anemia was found in 5(62.50%) of patients with MCD, elevated ESR in 8(100%) 
and hyperlipidemia in all 8(100%) patients.None of the patients with MCD had 
hypocalcemia  
 
 
IgA NEPHROPATHY 
 
 Of the 50 patients studied 8 (16%) patients had IgA nephropathy.All the 8 
patients with IgAN were females.Among the eight patients with IgAN 3(37.5%) 
patients were in the age group of 12 to 20 years , 5(62.50%) in 21 to 40 years age 
group and none were above 40 years of age .In patients with IgAN 7(87.50%) 
patients had renal insufficiency[68.7% in   study of A Bakshi et al] 9 .Of the 8 
patients with IgAN 6(75%) had hypertension[53.1  in the  study  of A  Bakshi et 
al] 9 . 2(25%) patients with stage 1 and 4(50%) with stage 2 hypertension . 
Microscopic hematuria was found in 7 (87.50%) patients [81.2% in the study of A 
Bakshi et al] 9. Nephrotic range of proteinuria was found in 5(62.50%) of patients 
with IgAN and 3(37.50%) had non-nephrotic range of proteinuria. Anemia was 
found in 4(50%) of patients with IgAN. Elevated ESR in 7(87.50%), 
hyperlipidemia in 7 (87.50%) and hypocalcemia in 3(37.50%) were found in 
patients with IgAN. 
 
 
MESANGIOPROLIFERATIVE GLOMERULONEPHRITIS 
 
 
 Of the 50 patients studied 7(14%) had mesangioproliferative GN, 
5(71.42%) of the patients were male [64.92% males in the study of Usha et al] 10 
and the remaining 2(28.57%) were females. Mesangioproliferative GN was 
common in the age group of 21 to 40 years with 4(57.14%) of patients in that age 
group, 1(14.28%) was below 20 years, and 2(28.57%) were above 40 years of age. 
Renal insufficiency was found in 4(57.14%) of the total 7 patients with 
mesangioproliferativeGN [18.33% in the study of Usha et al] 10. 4(57.14%) 
patients had stage 1 hypertension, 2(28.57%) had microscopic hematuria [5.78 in 
the study of Usha et al] 10.4(57.14%) patients had nephrotic range proteinuria and 
3(42.85%) patients had subnephrotic range. Anemia was found in 2(28.57%) 
patients, elevated ESR in 6(85.71%), hyperlipidemia in 5(71.42%). 
 
MEMBRANOUS NEPHROPATHY 
 
 
 6(12%) of the 50 patients studied had membranous nephropathy. This type 
was more prevalent in the age group of 21 to 40 years, 4(66.66%) patients were in 
this age group and 1(16.66%) patients were in the age group of less than 20 years 
and more than 40 years each. Renal failure was prevalent in only 1(16.66%) 
patient with membranous nephropathy [< 10% in the study of Noel LH et al 32% 
in the study of AD Parekh et al] 11 and Hypertension was prevalent in 3(50%) of 
the 6 patients with membranous nephropathy [40% in the study of AD Parekh et 
al] 11 and all the 3 had stage 2 hypertension. Hematuria was prevalent in 
2(33.33%) patients [30-50% in the study of Noel LH et al 16 and 44% in the study 
of AD Parekh et al] 11. Nephrotic range of proteinuria was prevalent in 5(83.33%) 
of patients with membranous nephropathy and only 1(16.66%) had subnephrotic 
range of proteinuria. Anemia and elevated ESR was found in 3(50%) of patients 
with membranous nephropathy and hyperlipidemia was prevalent in 5(83.33%) of 
the patients. 
 
LUPUS NEPHRITIS 
 
 
 Of the 50 patients studied 6(12%) of them had lupus nephritis and all the 
6(100%) were female.4 (66.66%) of the 6 patients with lupus nephritis were in the 
age group between 21 to 40 years and 1(16.66%) each in the other two age groups. 
Hypertension and renal insufficiency were prevalent in 4(66.66%) with lupus 
nephritis [83% Hypertension and 72% renal insufficiency in the study of A 
Bakshi] 9. 4(66.66%) had nephrotic range proteinuria [against 25% in the study of 
Wallace et al] 12 and 2(33.33%) patients had subnephrotic range. 3(50%) patients 
with lupus nephritis had microscopic hematuria .All the 6(100%) with lupus 
nephritis had hyperlipidemia and elevated ESR 4 (66.66%) had anemia. 
 
 
MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (MPGN) 
 
 3(6%) had MPGN among the 50 patients studied. 2(66.66%) of the patients 
were in the age group of 21 to 40 years and 1(33.33%) patient was below 20 years 
of age .All the 3(100%) patients with MPGN had renal insufficiency and 
microscopic hematuria was found in 2(66.66%) patients, 2(66.66%) of patients 
with MPGN had proteinuria in the nephrotic range and 1(33.33%) in subnephrotic 
range. All the 3(100%) patients with MPGN had hyperlipidemia and elevated ESR 
1(33.33%) patient had anemia. 
 
AMYLOIDOSIS 
 
 Only one among the 50 patients studied had amyloidosis. The patient with 
amyloidosis had renal insufficiency, microscopic hematuria, subnephrotic range of 
proteinuria and normal blood pressure. Anemia was present in the patient,ESR 
was elevated no hyperlipidemia was present .  
 
RENAL INSUFFICIENCY 
 
 
 Among the various parameters taken for the study renal insufficiency was 
found in 23(46%) patients, against 47.16% in the study conducted in 
Visakhapatnam 13, 45% in the study in Bangalore 14. Among the 23 patients with 
renal insufficiency 17 were females and 6 were males. None of the 8(100%) with 
MCD had renal insufficiency, whereas all the 3(100%) patients with MPGN, 
1(100%) patient with amyloidosis, 7 (87.5%) of patients with IgAN[68.7% in the 
study of A Bakshi et al.] 9, 3 (27.27%) of 11 patients with FSGS [23.3% in the 
study of A Bakshi et al] 9, 4(66.6%) of 6 patients with lupus nephritis[72% in the 
study of A Bakshi et  al.] 9, 1(16.6%) of 6 patients with membranous nephropathy 
[<10% in the study of Noel LH et al16 and 32% in the study of AD Parekh et  al] 11 
, 4(57.14%) of 7 patients with mesangioproliferative GN [18.33% in the study of 
Usha et al.] 10, had renal insufficiency. All the patients with renal insufficiency 
were divided into three groups depending on the serum creatinine value as follows  
 
I – Serum creatinine 1.5 to 2.9 mgs/dl  
 
II – Serum creatinine 3.0 to 4.9 mgs/dl  
 
III – Serum creatinine > 5.0 mgs / dl  
 
 Among the 23 patients with renal insufficiency 14 patients fell in-group I, 6 
in-group II, 3 in-group III. 15 (50%) of the 30 patients in the age group of 21 to 40 
years, 3(50%) of the 6 patients in the age group above 40 years of age had renal 
insufficiency. whereas only 5(35.71%) of the 14 patients in the younger age group 
of 12 to 20 years had renal insufficiency.  
 
 
MICROSCOPIC HEMATURIA 
 
 On urine microscopic examination >3RBCs / HPF were taken as positive 
for hematuria. Among the total 50 patients studied 20(40%) had microscopic 
hematuria, against 37.8% in Chandigarh 7, 77.35% in Vishakapatnam 13 and 41.3% 
in Lucknow study 15. Among the 20 patients with microscopic hematuria 13 were 
females and 7 were males. According to the age group 7(50%) of the patients in 
the age group of 12to 20 years, 11(36.66%) in the age group of 21 to 40 years and 
2(33.33%) in the age group above 40 years had microscopic hematuria. None of 
the patients with MCD had hematuria, whereas 7(87.5%) of 8 patients with IgAN 
had microscopic hematuria [81.2% in the study of A Bakshi et al.] 9, similarly 2 
(66.66%) of the 3 patients with MPGN, 3(50%) of 6 patients with lupus nephritis, 
4(36.36%) of 11 patients with FSGS [46.67% in the study of Jayakumar et al.] 8, 
2(33.33%) of 6 patients with membranous nephropathy [against 30-50% in the 
study of Neol LH et al 16 and 44% in the study of AC Parekh et al. 11], 2 (28.57%) 
of 7 patients with mesangioproliferative nephritis had microscopic hematuria 
[30% in the study of Usha et al] 10. 
 
HYPERTENSION 
 
 Of the 50 patients studied 22(44%) had hypertension (>140/90 mm Hg), 
against 33.2% in Chandigarh and 25.9% in Lucknow studies. Of the 22 patients 
with hypertension 7(31.81%) were male and 15(68.18%) were female. According 
to the age group only 2(9.09%) were in the age group of 12 to 20 years, 
17(77.27%) in the age group of 21 to 40 years and 3(13.63%) were in the age 
group of 40 to 60 years had hypertension. The prevalence of hypertension was 
highest in patients with IgAN where 6(75%) of 8 patients had hypertension 
[53.1% in the study of A Bakshi et al.] 9 .The prevalence of hypertension was least 
in patients with FSGS where only 2(18.18%) of 11 patients had hypertension 
13.3% in the study of Jayakumar et al] 8. 4(6.66%) of 6 patients with lupus 
nephritis [83% in the study of A Bakshi et al], 2(25%) of patients with MCD 
[against 20-30% in Nolasco F, et al. – study] 17, 3(50%) of patients with 
membranous nephropathy [40% in the study of AD Parekh  et al.] 11 , 4(57.14%) 
of patients with mesangioproliferative GN and 1(33.33%) of 3 patients with 
MPGN had hypertension[against 30%] .Of the 22 patients with hypertension 
13(59.09%) had stage 1 (BP 140-159/90-99 mm Hg)  and 9(40.90%) patients had 
stage 2 (BP > 150/100 mm Hg) hypertension. 
 
 
 
 
PROTEINURIA 
 
 
 In all the patients studied 24-hour urine sample was collected, the amount 
of proteinuria was quantified and patients were divided into two groups as follows. 
Patients with nephrotic range of proteinuria (>3.5 gms/ 24 hours) and 
Subnephrotic range of proteinuria (1 –3.4 gms / 24 hours) .32 (64%) of the fifty 
patients had nephrotic range and 18 (36%) had subnephrotic range of proteinuria 
.The average amount of proteinuria in 24 hours collection was 6.29 grams. The 
mean amount of proteinuria was highest in patients with MCD (7.17 gms / 24 
hours) [5.13 gms in the study of A Bakshi et al] 9, followed closely by patients 
with FSGS (6.13 gms/ 24 hours) [4-6 gms in the Southwest Pediatric Nephrology 
Study group 18 and 3.31 gms in the study of Jayakumar et al. 8] and membranous 
nephropathy (5.3 gms/ 24 hours) [2.58 gms in the study of A Bakshi et al.9]. 
Nephrotic range of proteinuria was present in 6(54.54%%) of patients with FSGS, 
5(62.5%) of patients with IgAN, 4(66.66%) of patients with lupus nephritis 
[against 25% in the study of Wallace et al 14], 6(75%) of patients with MCD , 
5(83.33%) of patients with membranous nephropathy , 2(66.6%) of patients with 
MPGN [against 80% in the study of Mallik NP et al] and  4(57.14%) of patients 
with mesangioproliferative GN .  
 
 
 
 
 
 
 
 
 
 
 
 
 
SUMMARY 
 
 1. 50 patients with proteinuria more than 1 gram per 24 hours above the age 
of 12 years were biopsied for renal histopathological examination. There were 
32(65%)  females and 18(36%)  males, with a mean age of 27.54 years. 
 2. The commonest histopathological type found was FSGS in 11(22%) 
patients followed by, IgAN in8 (16%), MCD in 8(16%), mesangioproliferative in 
7(14%), membranous nephropathy in 6(12%), lupus nephritis in 6(12%), MPGN 
in 3(6%) and amyloidosis in 1(2%). 
 3. MCD was commonest histopathological type in age group of less than 20 
years of age, FSGS in 21 to 40 years and mesangiproliferative glomerulonephritis 
above 40 years of age group. 
 4. 23(46%) of the 50 patients had renal insufficiency and is common in 
patients with MPGN (100%), amyloidosis (100%), IgAN (87.5%) and lupus 
nephritis (66.66%). None of the patients with MCD had renal insufficiency. 
 5.20(40%) of the total patients studied had microscopic hematuria 
 6. 22(44%) of the 50 patients studied had hypertension. The prevalence of 
hypertension was highest in patients with IgAN. 
 7. 32(64%) of patients had nephrotic range of proteinuria; where the mean 
amount of proteinuria was 6.29 grams per 24 hours. The prevalence of nephrotic 
range of proteinuria was highest in patients with MCD, where 5(83.33%) had 
nephrotic range of proteinuria. 
 CONCLUSION 
¾  The most common histopathological type was Focal segmental 
glomerulosclerosis (FSGS). 
¾  Renal insufficiency was common in patients with Membranoproliferative 
glomerulonephritis (MPGN). 
¾  Hypertension was common in patients with IgA nephropathy (IgAN). 
¾  Nephrotic range proteinuria was common in patients with Minimal change 
disease (MCD). 
¾  Microscopic hematuria was common in patients with IgA nephropathy 
(IgAN). 
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NAME: 
AGE: 
SEX: 
N.C no: 
24-HOUR URINARY PROTEIN (Gms/dl): 
URINE RBC’S: 
BLOOD UREA: 
SERUM CREATININE: 
HEMOGLOBIN: 
TOTAL LEUKOCYTE COUNT: 
ESR: 
SERUM CHOLESTEROL: 
SERUM ELECTROLYTES: 
BLOOD PRESSURE: 
ULTRASONOGRAM OF KIDNEY  
 RIGHT KIDNEY SIZE: 
 LEFT KIDNEY SIZE: 
 CORTICAL ECHOGENECITY: 
RENAL BIOPSY - HISTOPATHOLOGY: 
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